Compare MCD & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCD | TMO |
|---|---|---|
| Founded | 1940 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6B | 164.3B |
| IPO Year | 1996 | 1996 |
| Metric | MCD | TMO |
|---|---|---|
| Price | $272.34 | $467.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 29 | 18 |
| Target Price | $344.17 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 4.2M | 2.2M |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.56% | 0.40% |
| EPS Growth | 4.92 | ★ 7.32 |
| EPS | 2.78 | ★ 4.43 |
| Revenue | ★ $26,885,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | $7.65 | $6.55 |
| Revenue Next Year | $6.00 | $5.11 |
| P/E Ratio | ★ $97.50 | $104.74 |
| Revenue Growth | 3.72 | ★ 14.47 |
| 52 Week Low | $270.08 | $398.08 |
| 52 Week High | $341.75 | $643.99 |
| Indicator | MCD | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 48.17 |
| Support Level | $271.91 | $456.87 |
| Resistance Level | $311.08 | $494.30 |
| Average True Range (ATR) | 5.22 | 11.94 |
| MACD | -0.31 | -1.13 |
| Stochastic Oscillator | 10.28 | 27.86 |
McDonald's is the world's largest restaurant brand, with nearly $139 billion in systemwide sales across more than 45,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 62%), with the remainder stemming from company-operated restaurants across three segments: the United States (39% of systemwide sales), international operated markets (35%), and international developmental/licensed markets (26%).
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).